Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients

被引:21
|
作者
Ceccarini, Jenny [1 ,2 ]
Leurquin-Sterk, Gil [1 ,2 ]
Crunelle, Cleo Lina [3 ,4 ]
de Laat, Bart [1 ,2 ,5 ]
Bormans, Guy [6 ]
Peuskens, Hendrik [7 ,8 ]
Van Laere, Koen [1 ,2 ,5 ]
机构
[1] UZ Leuven, Dept Nucl Med & Mol Imaging, Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Imaging & Pathol, Herestr 49, B-3000 Leuven, Belgium
[3] Univ Antwerp, Toxicol Ctr, Antwerp, Belgium
[4] Univ Ziekenhuis Brussel, Dept Psychiat, Brussels, Belgium
[5] Katholieke Univ Leuven, Mol Small Anim Imaging Ctr, MoSAIC, Leuven, Belgium
[6] Katholieke Univ Leuven, Lab Radiopharm, Leuven, Belgium
[7] Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium
[8] Klin Broeders Alexianen, Tienen, Belgium
关键词
mGluR5; alcohol addiction; alcohol abstinence; alcohol craving; TEST-RETEST REPRODUCIBILITY; PLUS-CONSTANT-INFUSION; MGLUR5; PET; VOLUME; BRAIN; SPECTROSCOPY; ACAMPROSATE; ASSOCIATION; F-18-FPEB; SEEKING;
D O I
10.2967/jnumed.119.228825
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Animal models of alcohol dependence and relapse demonstrate an important role of the glutamatergic system, in particular, cerebral metabotropic glutamate receptor 5 (mGluR5). F-18-3-fluoro-5-[(pyridin3-yl)ethynyl]benzonitrile (F-18-FPEB) PET has revealed that chronic alcohol use leads to decreased limbic mGluR5 availability, which was associated with less craving. Here, we tested whether the state of decreased mGluR5 availability in alcohol-dependent patients normalizes during abstinence (at 2 and 6 mo of detoxification) and whether initial mGluR5 imaging parameters can predict individual relapse. Methods: F-18-FPEB scans were performed for 16 recently detoxified alcohol-dependent patients (baseline condition), 2 mo after detoxification (n = 10), and 6 mo after detoxification (n = 8); 32 age- and sex-matched controls were included for comparison. mGluR5 availability was quantified by the F-18-FPEB total distribution volume using both voxel-by-voxel and volume-of-interest analyses. During follow-up, craving was assessed using the Desire for Alcohol Questionnaire, and alcohol consumption was assessed using the timeline follow-back method and monitored by hair ethyl glucuronide analysis. Results: During abstinence, alcohol-dependent patients showed sustained recovered mGluR5 availability in cortical and subcortical regions compared with the baseline, up to the levels observed in controls, after 6 mo in most areas except for the hippocampus, nucleus accumbens, and thalamus. Higher striatopallidal mGluR5 availability was observed at the baseline in patients who had a relapse during the 6-mo follow-up period (+25.1%). Also, normalization of striatal mGluR5 to control levels was associated with reduced craving ("desire and intention to drink" and "negative reinforcement"; r = 0.72-0.94). Conclusion: Reduced cerebral mGluR5 availability in alcohol-dependent patients recovers during abstinence and is associated with reduced craving. Higher striatal mGluR5 availability in alcohol-dependent users may be associated with long-term relapse.
引用
收藏
页码:256 / 262
页数:7
相关论文
共 50 条
  • [1] Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent subjects
    Ceccarini, Jenny
    Leurquin-Sterk, Gil
    Crunelle, Cleo
    De laat, Bart
    Bormans, Guy
    Peuskens, Hendrik
    Van Laere, Koen
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [2] Cognitive functions in abstinent alcohol-dependent patients
    Kopera, Maciej
    Wojnar, Marcin
    Brower, Kirk
    Glass, Jennifer
    Nowosad, Izabela
    Gmaj, Bartlomiej
    Szelenberger, Waldemar
    ALCOHOL, 2012, 46 (07) : 665 - 671
  • [3] Lower Limbic Metabotropic Glutamate Receptor 5 Availability in Alcohol Dependence
    Leurquin-Sterk, Gil
    Ceccarini, Jenny
    Crunelle, Cleo L.
    de Laat, Bart
    Verbeek, Jef
    Deman, Stephanie
    Neels, Hugo
    Bormans, Guy
    Peuskens, Hendrik
    Van Laere, Koen
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (04) : 682 - 690
  • [4] Anxiety disorders among abstinent alcohol-dependent patients
    Roberts, MC
    Emsley, RA
    Pienaar, WP
    Stein, DJ
    PSYCHIATRIC SERVICES, 1999, 50 (10) : 1359 - 1361
  • [5] Prolactin response to fenfluramine in abstinent, alcohol-dependent patients
    Porter, Richard J.
    Sellman, Doug
    Joyce, Peter R.
    Davies, Julia
    Frampton, Chris
    ADDICTION BIOLOGY, 2008, 13 (3-4) : 380 - 385
  • [6] Osteoprotegerin Levels Decrease in Abstinent Alcohol-Dependent Patients
    Malik, Peter
    von Gleissenthall, Gabriele
    Gasser, Rudolf W.
    Moncayo, Roy
    Giesinger, Johannes M.
    Mechtcheriakov, Sergei
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 (06) : 1235 - 1240
  • [7] AGOMALATINE IS EFFECTIVE IN REDUCING INSOMNIA IN ABSTINENT ALCOHOL-DEPENDENT PATIENTS
    Grosshans, M.
    Mutschler, J.
    Luderer, M.
    Mann, K.
    Kiefer, F.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [8] Clinical signification of pathological impulsivity in abstinent alcohol-dependent patients
    Jimenez, M.
    Iribarren, M.
    Rodriguez, R.
    Rubio, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S493 - S493
  • [9] Levels of emotional awareness in alcohol-dependent patients and abstinent alcoholics
    Bochand, L.
    Nandrino, J-L.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2010, 36 (04): : 334 - 339
  • [10] Lower activity of serum peptidases in abstinent alcohol-dependent patients
    Maes, M
    Lin, AH
    Bonaccorso, S
    Vandoolaeghe, E
    Song, C
    Goossens, F
    De Meester, I
    DeGroote, J
    Neels, H
    Scharpé, S
    Janca, A
    ALCOHOL, 1999, 17 (01) : 1 - 6